caffeic acid phenethyl ester has been researched along with ag 30 in 1 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (ag 30) | Trials (ag 30) | Recent Studies (post-2010) (ag 30) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 9 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennis, K; Busserolles, J; C Chatelain, F; Chapuy, E; Deokar, H; Ducki, S; Eschalier, A; Lesage, F; Pereira, V; Rodrigues, N; Vivier, D | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and ag 30
| Article | Year |
|---|---|
Synthesis and structure-activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel.
Topics: Analgesics; Animals; Caffeic Acids; Cinnamates; Esters; Male; Mice; Models, Molecular; Pain; Potassium Channels, Tandem Pore Domain; Quantitative Structure-Activity Relationship; Xenopus | 2014 |